Cas:58090-96-3 butyl prop-2-enoate,4-methyl-2-methylidenepentanoic acid,prop-2-enoic acid manufacturer & supplier

We serve Chemical Name:butyl prop-2-enoate,4-methyl-2-methylidenepentanoic acid,prop-2-enoic acid CAS:58090-96-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

butyl prop-2-enoate,4-methyl-2-methylidenepentanoic acid,prop-2-enoic acid

Chemical Name:butyl prop-2-enoate,4-methyl-2-methylidenepentanoic acid,prop-2-enoic acid
CAS.NO:58090-96-3
Synonyms:Acrylic acid,butyl acrylate,isobutyl acrylate polymer;2-Propenoic acid,polymer with butyl 2-propenoate and 2-methylpropyl 2-propenoate;4-methyl-2-methylidene-pentanoic acid
Molecular Formula:C17H28O6
Molecular Weight:328.40100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:145.9ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:100.90000
Exact Mass:328.18900
LogP:3.44600

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Acrylic acid,butyl acrylate,isobutyl acrylate polymer chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-methyl-2-methylidene-pentanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acrylic acid,butyl acrylate,isobutyl acrylate polymer Use and application,2-Propenoic acid,polymer with butyl 2-propenoate and 2-methylpropyl 2-propenoate technical grade,usp/ep/jp grade.


Related News: The additional GMP labs will be able to develop and manufacture highly potent API (HPAPI) under GMP standards. The expanded labs and manufacturing facilities are expected to come online between 1Q22 and 3Q22. 2-(2,3-dimethylphenylamino)-5-nitrobenzenesulfonamide manufacturers The relationship between a CDMO and the company also depends on influencing aspects such as transparent communication, involvement at every step, and support while dealing with challenges. [(4-amino-6-phenyl-[1,3,5]triazin-2-ylamino)-methyl]-methyl-carbamic acid ethyl ester suppliers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 (4-o-Tolyl-piperazin-1-yl)-acetic acid N’-(2-methyl-1H-indol-3-ylmethyl)-hydrazide vendor & factory.